Author:
Baxa Jan,Vondráková Alena,Matoušková Táňa,Růžičková Olga,Schmidt Bernhard,Flohr Thomas,Sedlmair Martin,Ferda Jiří
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference27 articles.
1. Raz J, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons M (2007) Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 132:193–199
2. Savas P, Hughes B, Solomon B (2013) Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer. J Thorac Dis 5:S579–S592
3. Van Persijn van Meerten EL, Gelderblom H, Bloem JL (2010) RECIST revised: implications for radiologist. A review article on the modified RECIST guidelines. Eur Radiol 20:1456–1467
4. Nathan PD, Vinayan A, Stott D, Juttla J, Goh V (2010) CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies. Cancer Biol Ther 9:15–19
5. Walker CM, Chung JH, Abbott GF et al (2012) Mediastinal lymph node staging: from noninvasive to surgical. AJR Am J Roentgenol 199:W54–W56